These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1453 related items for PubMed ID: 18583464

  • 41. Aerobic Training Improves Quality of Life in Women with Polycystic Ovary Syndrome.
    Costa EC, DE Sá JCF, Stepto NK, Costa IBB, Farias-Junior LF, Moreira SDNT, Soares EMM, Lemos TMAM, Browne RAV, Azevedo GD.
    Med Sci Sports Exerc; 2018 Jul; 50(7):1357-1366. PubMed ID: 29443823
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.
    Ravn P, Haugen AG, Glintborg D.
    Minerva Endocrinol; 2013 Mar; 38(1):59-76. PubMed ID: 23435443
    [Abstract] [Full Text] [Related]

  • 44. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.
    Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R.
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2670-8. PubMed ID: 18460557
    [Abstract] [Full Text] [Related]

  • 45. Lifestyle modification intervention among infertile overweight and obese women with polycystic ovary syndrome.
    Mahoney D.
    J Am Assoc Nurse Pract; 2014 Jun; 26(6):301-8. PubMed ID: 24170708
    [Abstract] [Full Text] [Related]

  • 46. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
    Esfahanian F, Zamani MM, Heshmat R, Moini nia F.
    J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
    [Abstract] [Full Text] [Related]

  • 47. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D.
    Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
    Huber-Buchholz MM, Carey DG, Norman RJ.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1470-4. PubMed ID: 10199797
    [Abstract] [Full Text] [Related]

  • 50. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes.
    Wycherley TP, Brinkworth GD, Noakes M, Buckley JD, Clifton PM.
    Diabetes Obes Metab; 2008 Nov; 10(11):1062-73. PubMed ID: 18435772
    [Abstract] [Full Text] [Related]

  • 51. Increased fibre and reduced trans fatty acid intake are primary predictors of metabolic improvement in overweight polycystic ovary syndrome-Substudy of randomized trial between diet, exercise and diet plus exercise for weight control.
    Nybacka Å, Hellström PM, Hirschberg AL.
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):680-688. PubMed ID: 28727165
    [Abstract] [Full Text] [Related]

  • 52. Effects of aerobic or combined aerobic resistance exercise on body composition in overweight and obese adults: gender differences. A randomized intervention study.
    Sanal E, Ardic F, Kirac S.
    Eur J Phys Rehabil Med; 2013 Feb; 49(1):1-11. PubMed ID: 22569489
    [Abstract] [Full Text] [Related]

  • 53. Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children.
    Shalitin S, Ashkenazi-Hoffnung L, Yackobovitch-Gavan M, Nagelberg N, Karni Y, Hershkovitz E, Loewenthal N, Shtaif B, Gat-Yablonski G, Phillip M.
    Horm Res; 2009 Feb; 72(5):287-301. PubMed ID: 19844115
    [Abstract] [Full Text] [Related]

  • 54. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS.
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [Abstract] [Full Text] [Related]

  • 55. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A, Fallahzadeh H, Nadjarzadeh A.
    J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
    [Abstract] [Full Text] [Related]

  • 56. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.
    Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, Boscaro M.
    J Endocrinol Invest; 2004 May; 27(5):424-9. PubMed ID: 15279073
    [Abstract] [Full Text] [Related]

  • 57. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis.
    Lim SS, Norman RJ, Davies MJ, Moran LJ.
    Obes Rev; 2013 Feb; 14(2):95-109. PubMed ID: 23114091
    [Abstract] [Full Text] [Related]

  • 58. Perceived exercise barriers are reduced and benefits are improved with lifestyle modification in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Thomson RL, Buckley JD, Brinkworth GD.
    BMC Womens Health; 2016 Mar 09; 16():14. PubMed ID: 26960762
    [Abstract] [Full Text] [Related]

  • 59. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.
    Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, Colao A, Vigorito C, Zullo F, Orio F.
    Hum Reprod; 2008 Mar 09; 23(3):642-50. PubMed ID: 18158291
    [Abstract] [Full Text] [Related]

  • 60. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
    Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, Basora J, Fitó M, Corella D, Serra-Majem L, Wärnberg J, Romaguera D, Estruch R, Vidal J, Martínez JA, Arós F, Vázquez C, Ros E, Vioque J, López-Miranda J, Bueno-Cavanillas A, Tur JA, Tinahones FJ, Martín V, Lapetra J, Pintó X, Daimiel L, Delgado-Rodríguez M, Matía P, Gómez-Gracia E, Díez-Espino J, Babio N, Castañer O, Sorlí JV, Fiol M, Zulet MÁ, Bulló M, Goday A, Martínez-González MÁ, PREDIMED-Plus investigators.
    Diabetes Care; 2019 May 09; 42(5):777-788. PubMed ID: 30389673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 73.